##### Table of Contents



SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q/A
(Amendment No. 1)

| |  |       |  |                                                                                              
| |  | ----- |  | ---------------------------------------------------------------------------------------------
| |  | (X)   |  | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF
THE SECURITIES EXCHANGE ACT OF 1934     
| |  |       |  |                                                                                              
| |  |       |  | For the quarterly period ended June 30, 2002                                                 
| |  |       |  |                                                                                              
| |  | (   ) |  | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF
THE SECURITIES AND EXCHANGE ACT OF 1934
| |  |       |  |                                                                                              
| |  |       |  | for the
transition period from
to .                                                          

Commission File Number

333-92825

---



MAXXIM MEDICAL, INC.

---

(Exact name of registrant as specified in its charter)


|                                |  |                                     
|------------------------------- |  | ------------------------------------
|TEXAS                           |  | 76-0291634                          
|                                |  |                                     
|(State or other jurisdiction of |  | (I.R.S. Employer Identification No.)
|incorporation or organization)  |  |                                     

|                                                      |  |           
|----------------------------------------------------- |  | ----------
|950 Winter Street, Suite 2900, Waltham, Massachusetts |  | 02451     
|                                                      |  |           
|(Address of principal executive offices)              |  | (Zip Code)

Registrants telephone number, including area code................................(781) 906-0700

Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15 (d) of the Securities and Exchange Act
of 1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports) and (2) has been subject to such
filing requirements for the past 90 days.

Yes [  ]                      No [X]

Indicate the number of shares outstanding of each of the issuers classes of
common stock:

|                              |  |                               
|----------------------------- |  | ------------------------------
|Class                         |  | Outstanding at August 13, 2002
|                              |  |                               
|Common Stock, $.001 par value |  | 26,743,627                    





---

TABLE OF CONTENTS



|                             |  |  |  |  |  |  |  | 
|---------------------------- |  |  |  |  |  |  |  | 
|Item 6. EXHIBITS AND REPORTS
|SIGNATURES                  
|CEO Certification           
|CFO Certification           



---



##### Table of Contents



Explanatory Note:

This amendment on Form 10-Q/A amends the registrants quarterly report on Form
10-Q/A for the three months ended June 30, 2002, and is being filed to add
exhibits 99.1 and 99.2.

PART II. Other Information




Item 6. EXHIBITS AND REPORTS

(a)  Exhibits

|     |  |                  
|---- |  | -----------------
|99.1 |  | CEO Certification
|99.2 |  | CFO Certification

(b)  Reports on Form 8-K



| |      
| | -----
| | None.

2



---



##### Table of Contents






SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.

|      |  |          |  |                      |  |                                                                                                                     
|----- |  | -------- |  | -------------------- |  | --------------------------------------------------------------------------------------------------------------------
|      |  |          |  | MAXXIM MEDICAL, INC.
|     
|Date: |  | 10/24/02 |  | By:                  |  | /s/ Mark S. SellersMark S. Sellers
Vice Chairman and Chief Financial Officer
          (principal financial officer)